which glp-1 is best for cardiovascular benefit and GIP–GLP-1 therapies benefits in diabetes and obesity | Gustavo Monnerat posted on the topic truemed-eligible Dose:1.00 mg GLP-1 receptor agonist and

which glp-1 is best for cardiovascular benefit and GIP–GLP-1 therapies benefits in diabetes and obesity | Gustavo Monnerat posted on the topic truemed-eligible Dose:1.00 mg GLP-1 receptor agonist and

GLP-1 receptor agonist and risk of erectile dysfunction in men with type 2 diabetes: a target trial emulation - eClinicalMedicine

The results also highlighted potential side effects: about a third of participants reported nausea or diarrhea, while about a quarter reported constipation

truemed-eligible

Dose:1.00 mg

That’s because the skin can stretch during weight gain and doesn’t always bounce back fully as elasticity decreases